<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Serologic responses to hepatitis B virus infection</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Serologic responses to hepatitis B virus infection</h1>
<div class="graphic"><div class="figure"><div class="ttl">Serologic responses to hepatitis B virus infection</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">Schematic representation of the serologic responses to acute and chronic HBV infection in relation to the serum ALT concentration.<br/>(Left panel) Acute infection is characterized initially by the presence of HBeAg, HBsAg, and HBV DNA beginning in the preclinical phase. IgM anti-HBc appears early in the clinical phase; the combination of this antibody and HBsAg makes the diagnosis of acute infection. Recovery is accompanied by normalization of the serum ALT, disappearance of HBV DNA, HBeAg to anti-HBe seroconversion, and subsequently HBsAg to anti-HBs seroconversion and switch from IgM to IgG anti-HBc. Thus, previous HBV infection is characterized by anti-HBs and IgG anti-HBc.<br/>(Right panel) Chronic infection is characterized by persistence of HBeAg (for a variable period), HBsAg, and HBV DNA in the circulation; anti-HBs is not seen (in approximately 20% of patients, a non-neutralizing form of anti-HBs can be detected). Persistence of HBsAg for more than 6 months after acute infection is considered indicative of chronic infection.</div><div class="graphic_footnotes">HBV: hepatitis B virus; ALT: alanine aminotransferase; HBeAg: hepatitis B e-antigen; anti-HBe: antibody to hepatitis B e-antigen; HBsAg: hepatitis B surface antigen; anti-HBs: antibody to hepatitis B surface antigen; IgM: immunoglobulin M; anti-HBc: antibody to hepatitis B core antigen; IgG: immunoglobulin G.</div><div id="graphicVersion">Graphic 69344 Version 5.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
